JP2005515199A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005515199A5 JP2005515199A5 JP2003548816A JP2003548816A JP2005515199A5 JP 2005515199 A5 JP2005515199 A5 JP 2005515199A5 JP 2003548816 A JP2003548816 A JP 2003548816A JP 2003548816 A JP2003548816 A JP 2003548816A JP 2005515199 A5 JP2005515199 A5 JP 2005515199A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- atomoxetine
- treatment
- reuptake inhibitor
- norepinephrine reuptake
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 claims 6
- 229960002430 atomoxetine Drugs 0.000 claims 6
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 claims 4
- 208000016686 tic disease Diseases 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000016620 Tourette disease Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 208000021703 chronic tic disease Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 229940127221 norepinephrine reuptake inhibitor Drugs 0.000 claims 1
- 0 *c(cccc1)c1OC(CCN*)c1ccccc1 Chemical compound *c(cccc1)c1OC(CCN*)c1ccccc1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33449401P | 2001-11-30 | 2001-11-30 | |
| PCT/US2002/033628 WO2003047560A1 (en) | 2001-11-30 | 2002-11-12 | Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005515199A JP2005515199A (ja) | 2005-05-26 |
| JP2005515199A5 true JP2005515199A5 (https=) | 2006-01-05 |
Family
ID=23307469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003548816A Pending JP2005515199A (ja) | 2001-11-30 | 2002-11-12 | チック障害の治療のためのノルエピネフリン再取込インヒビターの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20050014843A1 (https=) |
| EP (1) | EP1455770B1 (https=) |
| JP (1) | JP2005515199A (https=) |
| KR (1) | KR20050044604A (https=) |
| AT (1) | ATE365035T1 (https=) |
| AU (1) | AU2002347984A1 (https=) |
| CA (1) | CA2466649A1 (https=) |
| DE (1) | DE60220825T2 (https=) |
| DK (1) | DK1455770T3 (https=) |
| ES (1) | ES2287338T3 (https=) |
| PT (1) | PT1455770E (https=) |
| WO (1) | WO2003047560A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
| CA2475763A1 (en) * | 2002-02-12 | 2003-08-21 | Cypress Bioscience, Inc. | Methods of treating attention deficit/hyperactivity disorder (adhd) |
| KR20060121178A (ko) * | 2003-12-12 | 2006-11-28 | 일라이 릴리 앤드 캄파니 | 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제 |
| JPWO2006077846A1 (ja) * | 2005-01-18 | 2008-06-19 | 田辺三菱製薬株式会社 | 注意欠陥／多動性障害治療薬 |
| US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| US20080031932A1 (en) * | 2006-08-04 | 2008-02-07 | Watson Laboratories, Inc. | Transdermal atomoxetine formulations and associated methods |
| KR102096165B1 (ko) | 2018-05-03 | 2020-04-01 | 노충구 | 틱 장애 개선 및 치료 효과를 가지는 약학적 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| IL56369A (en) * | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| US5281624A (en) * | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
| US6323242B1 (en) * | 1998-12-02 | 2001-11-27 | Peter Sterling Mueller | Treatment of disorders secondary to organic impairments |
| DE60022692T2 (de) * | 1999-07-01 | 2006-06-22 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen |
| PT1257277E (pt) * | 2000-02-24 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Novas combinacoes de farmacos |
| CA2431041A1 (en) * | 2001-01-02 | 2002-07-11 | Pharmacia & Upjohn Company | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
-
2002
- 2002-11-12 CA CA002466649A patent/CA2466649A1/en not_active Abandoned
- 2002-11-12 PT PT02784195T patent/PT1455770E/pt unknown
- 2002-11-12 DK DK02784195T patent/DK1455770T3/da active
- 2002-11-12 AU AU2002347984A patent/AU2002347984A1/en not_active Abandoned
- 2002-11-12 KR KR1020047008010A patent/KR20050044604A/ko not_active Withdrawn
- 2002-11-12 AT AT02784195T patent/ATE365035T1/de not_active IP Right Cessation
- 2002-11-12 JP JP2003548816A patent/JP2005515199A/ja active Pending
- 2002-11-12 ES ES02784195T patent/ES2287338T3/es not_active Expired - Lifetime
- 2002-11-12 EP EP02784195A patent/EP1455770B1/en not_active Expired - Lifetime
- 2002-11-12 US US10/495,303 patent/US20050014843A1/en not_active Abandoned
- 2002-11-12 DE DE60220825T patent/DE60220825T2/de not_active Expired - Fee Related
- 2002-11-12 WO PCT/US2002/033628 patent/WO2003047560A1/en not_active Ceased
-
2008
- 2008-04-01 US US12/060,318 patent/US20080200555A1/en not_active Abandoned